{"entities":{"Q40558":{"pageid":30926,"ns":120,"title":"Item:Q40558","lastrevid":130713,"modified":"2026-08-13T06:25:09Z","type":"item","id":"Q40558","labels":{"mul":{"language":"mul","value":"6C4E.2"},"pt-br":{"language":"pt-br","value":"Depend\u00eancia de outra subst\u00e2ncia psicoativa especificada"},"en":{"language":"en","value":"Other specified psychoactive substance dependence"}},"descriptions":{"pt-br":{"language":"pt-br","value":"Depend\u00eancia de outra subst\u00e2ncia psicoativa especificada \u00e9 um transtorno de regula\u00e7\u00e3o do uso de uma subst\u00e2ncia especificada que surge do uso repetido ou cont\u00ednuo da subst\u00e2ncia especificada. O elemento caracter\u00edstico \u00e9 um forte impulso interno para usar a subst\u00e2ncia especificada, que \u00e9 manifestado por capacidade prejudicada de controlar o uso, aumento da prioridade dada ao uso em detrimento de outras atividades, e persist\u00eancia do uso apesar de danos ou consequ\u00eancias negativas. Essas experi\u00eancias s\u00e3o frequentemente acompanhadas de uma sensa\u00e7\u00e3o subjetiva de urg\u00eancia ou fissura para usar a subst\u00e2ncia especificada. Aspectos fisiol\u00f3gicos da depend\u00eancia tamb\u00e9m podem estar presentes, incluindo toler\u00e2ncia aos efeitos da subst\u00e2ncia especificada, sintomas de abstin\u00eancia ap\u00f3s a cessa\u00e7\u00e3o ou redu\u00e7\u00e3o no uso da subst\u00e2ncia especificada, ou uso repetido da subst\u00e2ncia especificada ou subst\u00e2ncias farmacologicamente semelhantes para prevenir ou aliviar os sintomas de abstin\u00eancia. As manifesta\u00e7\u00f5es da depend\u00eancia geralmente s\u00e3o evidentes durante um per\u00edodo de pelo menos 12 meses, mas o diagn\u00f3stico pode ser feito se o uso da subst\u00e2ncia especificada for cont\u00ednuo (di\u00e1rio ou quase di\u00e1rio) por pelo menos 3 meses."},"en":{"language":"en","value":"Other specified psychoactive substance dependence is a disorder of regulation of use of a specified substance arising from repeated or continuous use of the specified substance. The characteristic feature is a strong internal drive to use the specified substance, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use the specified substance. Physiological features of dependence may also be present, including tolerance to the effects of the specified substance, withdrawal symptoms following cessation or reduction in use of the specified substance, or repeated use of the specified substance or pharmacologically similar substances to prevent or alleviate withdrawal symptoms. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if use of the specified substance is continuous (daily or almost daily) for at least 3 months."}},"aliases":{},"claims":{"P68":[{"mainsnak":{"snaktype":"value","property":"P68","hash":"37679c53f7b0c3da02516ac97857ecf2002a931c","datavalue":{"value":"https://id.who.int/icd/entity/1934475925","type":"string"},"datatype":"url"},"type":"statement","id":"Q40558$5AE8F6E4-5C79-45AA-A40E-C65DB01FC8DB","rank":"normal"}],"P67":[{"mainsnak":{"snaktype":"value","property":"P67","hash":"6d3162422a0661c82f5c7269bd3a996144324570","datavalue":{"value":"CID11:6C4E.2","type":"string"},"datatype":"string"},"type":"statement","id":"Q40558$59D29D57-5E8E-431A-87F7-AAC31CD146D7","rank":"normal"}],"P70":[{"mainsnak":{"snaktype":"value","property":"P70","hash":"01c2237bc390ba336fe887ddc7ea7a45e6a058b8","datavalue":{"value":"dki-india-6C4E.2","type":"string"},"datatype":"string"},"type":"statement","id":"Q40558$C33910B7-EA8C-498D-A1E8-E7E09502D734","rank":"normal"}],"P86":[{"mainsnak":{"snaktype":"value","property":"P86","hash":"a96031634b9f5dafddaf781bbba3adea6bb64ef4","datavalue":{"value":"Conclu\u00eddo","type":"string"},"datatype":"string"},"type":"statement","id":"Q40558$E455BF58-2C02-4459-BFE9-F3BBCD71E68E","rank":"normal"}],"P78":[{"mainsnak":{"snaktype":"value","property":"P78","hash":"5f9b5be68b7400da549761cf15abfdbc4d1e075b","datavalue":{"value":"https://pauloleads.com.br/cases-publicos/","type":"string"},"datatype":"url"},"type":"statement","id":"Q40558$A8FCD196-E247-4947-A5B0-A0B329BA1AD4","rank":"normal"}],"P80":[{"mainsnak":{"snaktype":"value","property":"P80","hash":"92b8222fcbb75718504f915073a3f43bd4003d18","datavalue":{"value":{"time":"+2026-08-13T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q40558$941FE8E1-BCB5-40EB-8AC9-8680A118C4E5","rank":"normal"}],"P89":[{"mainsnak":{"snaktype":"value","property":"P89","hash":"5701ebe22ba90bb0519b2a99743bb73f6cf1c8bf","datavalue":{"value":{"entity-type":"item","numeric-id":16094,"id":"Q16094"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q40558$C8CEB7C1-B538-4197-8E04-F3C2BCDF2DB0","rank":"normal"}]},"sitelinks":{}}}}